Free Trial

ABVC BioPharma (ABVC) SEC Filings & 10K Form

ABVC BioPharma logo
$0.70 +0.11 (+19.59%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$0.69 -0.01 (-1.94%)
As of 02/21/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ABVC BioPharma SEC Filings

DateFilerForm TypeView
02/14/2025
4:13 PM
ABVC BioPharma (Subject)
Lind Global Fund II LP (Filed by)
Form SCHEDULE 13G/A
11/15/2024
2:26 PM
ABVC BioPharma (Filer)
Form 424B4
11/15/2024
2:28 PM
ABVC BioPharma (Filer)
Form 424B4
11/15/2024
2:30 PM
ABVC BioPharma (Filer)
Form 424B4
11/15/2024
2:31 PM
ABVC BioPharma (Filer)
Form 424B4
11/14/2024
6:33 PM
ABVC BioPharma (Subject)
Lind Global Fund II LP (Filed by)
Form SC 13G/A
11/14/2024
8:25 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:30 AM
ABVC BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
4:00 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
11:21 AM
ABVC BioPharma (Filer)
Form 424B4
10/18/2024
4:23 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:01 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
3:30 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
3:30 PM
ABVC BioPharma (Filer)
Form 424B4
08/16/2024
3:30 PM
ABVC BioPharma (Filer)
Form 424B4
08/16/2024
3:31 PM
ABVC BioPharma (Filer)
Form 424B4
08/15/2024
6:00 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
2:18 PM
ABVC BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
4:15 PM
ABVC BioPharma (Filer)
Form 424B5
08/01/2024
11:15 PM
ABVC BioPharma (Filer)
Form EFFECT
07/26/2024
3:30 PM
ABVC BioPharma (Filer)
Form POS AM
07/23/2024
4:00 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
11:15 PM
ABVC BioPharma (Filer)
Form EFFECT
06/25/2024
4:15 PM
ABVC BioPharma (Filer)
Form 8-K/A
06/24/2024
4:15 PM
ABVC BioPharma (Filer)
Form 8-K/A
06/21/2024
4:02 PM
ABVC BioPharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/24/2024
7:00 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
4:00 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
1:31 PM
ABVC BioPharma (Filer)
Form 424B4
05/15/2024
4:00 PM
ABVC BioPharma (Filer)
Form NT 10-Q
05/15/2024
8:00 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
8:27 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
11:15 PM
ABVC BioPharma (Filer)
Form EFFECT
04/25/2024
1:38 PM
ABVC BioPharma (Filer)
Form POS AM
04/19/2024
4:26 PM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
7:30 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
1:47 PM
ABVC BioPharma (Filer)
Form 424B4
04/01/2024
11:15 PM
ABVC BioPharma (Filer)
Form EFFECT
03/26/2024
7:35 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:30 PM
ABVC BioPharma (Filer)
Form DEFA14A
03/22/2024
4:01 PM
ABVC BioPharma (Filer)
Form S-1/A
Collect $7k per month from Tesla’s SECRET dividend (Ad)

There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?

Click here to uncover Tesla's hidden income secret.
03/14/2024
11:08 AM
ABVC BioPharma (Filer)
Form DEFA14A
03/14/2024
10:33 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
8:04 AM
ABVC BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
4:14 PM
ABVC BioPharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/29/2024
3:32 PM
ABVC BioPharma (Filer)
Form 8-K/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ABVC) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners